Ikarian Capital’s Albireo Pharma Inc ALBO Stock Holding History

Ikarian Capital’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,883	Closed	-$595K	–	316
2021 Q1	$595K	Hold	16,883	–	–	0.02%	252
2020 Q4	$633K	Buy	+16,883	New	+$614K	0.03%	186

Other funds holding ALBO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Ikarian Capital's ALBO Position: Q2 2021 in Review

Ikarian Capital sold out of Albireo Pharma Inc (ALBO) in Q2 2021, closing a stake of 16,883 shares — an estimated $595K sold.

Ikarian Capital first reported a position in ALBO in Q4 2020 and held it in 2 quarters. The position peaked at $633K in Q4 2020. 99 funds tracked by Wall St. Rank hold ALBO as of Q2 2021.

Ikarian Capital reported no remaining Albireo Pharma Inc position as of Q2 2021 after selling out during the quarter.
Ikarian Capital sold 16,883 Albireo Pharma Inc shares in Q2 2021, an estimated $595K.
Ikarian Capital first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 2 quarters.
Ikarian Capital's Albireo Pharma Inc position peaked at $633K in Q4 2020.
99 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2021.

Based on Ikarian Capital's 13F filing for Q2 2021, filed 16 Aug 2021.